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ABSTRACT The fusion protein of avian sarcoma and leukosis virus is likely to fold into a six-helix bundle as part of its ﬁnal
conﬁguration. A peptide, R99, inhibits fusion, probably by binding into the grooves of the triple-stranded coiled coil that becomes
the central core of the six-helix bundle. The stages at which the envelope protein (Env) of avian sarcoma and leukosis virus
subgroup A folds into a bundle during low pH-induced fusion were determined. Effector cells expressing Env were bound to
target cells expressing the cognate receptor Tva, and intermediates of fusion were created. R99 was added and the extent of
fusion inhibition was used to distinguish between a prebundle state with exposed grooves and a state in which the grooves were
no longer exposed. The native conformation of Env was not sensitive to R99. But adding a soluble form of Tva to effector cells
conferred sensitivity. Acidic pH applied at low temperature created an intermediate state of local hemifusion. Surprisingly, R99
caused these locally hemifused membranes to separate. This indicates that the grooves of Env were still exposed, that
prebundle conﬁgurations of Env stabilized hemifused states, and that binding of R99 altered the conformation of Env. In the
presence of an inhibitory lipid that blocks fusion before hemifusion, applying low pH at 37C created an intermediate in which
R99 was without effect. This suggests that the six-helix bundle can form before hemifusion and that subsequent conformational
changes, such as formation of the trimeric hairpin, are responsible for pore formation and/or growth.
INTRODUCTION
Class I fusion proteins of envelope viruses, by deﬁnition,
fold into six-helix bundles (6HBs) (Skehel and Wiley, 1998;
Eckert and Kim, 2001; Colman and Lawrence, 2003). These
proteins are assembled from three identical monomers and
each monomer consists of two subunits. The surface subunit
binds to receptors on target cells, and the transmembrane
(TM) subunit is responsible for membrane fusion. At some
point in the process of membrane fusion, the three TM
subunits fold into a hairpin structure; the N-terminal
segments are in the form of a trimeric helical coiled coil
and the C-terminal segments are bound peripherally, in an
antiparallel orientation, into each of the hydrophobic grooves
within the coiled coil. This creates a rigid, rodlike structure
known as a ‘‘trimeric hairpin’’ (Chan and Kim, 1998). The
stretch of the trimeric hairpin where bound C-terminal
segments are folded into a-helices is the portion of the
hairpin known as the 6HB.
The ﬁnal postfusion, trimeric hairpin structure for several
class I proteins has been determined; it is likely that all
proteins in this class have their fusion peptides and
membrane-spanning domains (MSDs) in close proximity
(Hughson, 1997; Weissenhorn et al., 1997; Chan and Kim,
1998). Recently, x-ray crystallography has determined the
structure of the ectodomains of fusion proteins from dengue
virus (Modis et al., 2004), Semliki Forest virus (Gibbons
et al., 2004), and tick-borne encephalitis virus (Bressanelli
et al., 2004) (all class II proteins which, by deﬁnition, do not
form 6HBs). Although these ectodomains are missing
relevant stretches of amino acids, judging from the structures
it is likely that fusion peptides and MSDs are brought into
proximity in the ectodomains’ ﬁnal, postfusion conforma-
tion. Because this motif of proximity appears to be universal,
it is expected to be critical to the fusion process. We and
others have speculated as to how the creation of this
proximity may be central to the fusion process (Chan and
Kim, 1998; Eckert and Kim, 2001; Russell et al., 2001;
Borrego-Diaz et al., 2003; Markosyan et al., 2003; Park et al.,
2003).
Synthetic peptides composed of the amino acid sequence
of the C-terminal helical region of a 6HB bind as helices into
the grooves of the coiled coil, and in so doing prevent bundle
formation and inhibit fusion. The ability of these peptides to
bind into the grooves of the coiled coil allows one to
determine the intermediate stage of fusion at which 6HBs
form: For proteins that are known to form 6HBs, the bundles
are extremely thermostable (Weissenhorn et al., 1998; Lu
et al., 1995; Baker et al., 1999; Malashkevich et al., 1999).
Therefore, if, after arresting fusion at an intermediate stage,
the addition of the peptide inhibits fusion, it follows that the
bundle has not yet formed. In contrast, if addition of the
peptide is without effect, then either the bundle has already
formed or the grooves have become inaccessible for some
other reason. Identifying the stage at which a bundle forms
allows one to infer the roles that bundle formation may serve
in the fusion process. This strategy has been successfully
employed to show that for HIV Env and SV5 F glycoproteins,
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membrane merger must occur in order for bundles to form
(Melikyan et al., 2000; Russell et al., 2001), and in the case
of HIV, all relevant copies of Env do not fold into a bundle
until after a fusion pore has formed (Markosyan et al., 2003).
Both HIV and SV5 fuse directly to the plasma
membrane at neutral pH. For viruses that fuse within the
acidic environment of an endosome, the stages of fusion
during which the fusion proteins fold into 6HBs have not
been determined. Inﬂuenza is the prototypic virus contain-
ing a class I fusion protein, hemagglutinin (HA), that
requires low pH for fusion. For HA, the 6HB comprises
only a small portion of the trimeric hairpin (Chen et al.,
1999), and here the stage at which the bundle forms has
not yet been identiﬁed. The folding of HA into a ﬁnal
trimeric hairpin structure is required for fusion (Borrego-
Diaz et al., 2003; Park et al., 2003); this folding induces
the formation and enlargement of the fusion pore (Borrego-
Diaz et al., 2003).
For avian sarcoma and leukosis virus (ASLV), binding of
Env to its receptor induces hydrophobic binding of Env to
the target membrane, probably via membrane-insertion of
fusion peptides (Hernandez et al., 1997; Damico et al., 1998;
Earp et al., 2003; Melikyan et al., 2004). It is now generally
agreed that a virus infects a cell only after encapsulation
within the low pH environment of an endosome (Mothes
et al., 2000; Diaz-Griffero et al., 2002; Narayan et al., 2003;
Melikyan et al., 2004). As would be expected, low pH is
needed for efﬁcient fusion between cells expressing ASLV
Env and target cells expressing the receptor (Mothes et al.,
2000; Earp et al., 2003; Melikyan et al., 2004). It has also
been biochemically demonstrated that ASLV Env undergoes
early conformational changes upon receptor binding, and
additional changes upon subsequent exposure to low pH
(Mothes et al., 2000; Matsuyama et al., 2004; Smith et al.,
2004).
ASLV is divided into 10 subgroups (A–J); each subgroup
requires a speciﬁc receptor for infectivity (Hunter, 1997).
ASLV-A utilizes a relatively small membrane protein,
designated Tva (Bates et al., 1993). The ectodomain of
Tva has a well-known cysteine-rich motif; this motif is
repeated seven times in the low density lipoprotein receptor.
A water-soluble form of Tva (sTva) that contains one copy of
this motif is sufﬁcient to initiate ASLV entry into receptor-
deﬁcient cells (Damico and Bates 2000).
The TM subunit of ASLV Env almost certainly forms
a 6HB (although this has not yet been established through
crystallography) because i), the hydrophobic pattern of the
amino acid sequence contains two heptad repeat domains
that should result in a trimeric coiled coil (Gallaher, 1996);
ii), the TM subunit sequence is homologous to the fusion
subunit GP2 of Ebola, shown by crystallography to form
a bundle (Weissenhorn et al., 1998; Malashkevich et al.,
1999); and iii), most importantly for this study, a
C-terminal peptide, R99—which encompasses the predicted
helical portion of the C-terminal segment of ASLV
Env—inhibits fusion and infection (Earp et al., 2003). It is
not known, however, when in the fusion process the 6HB
forms for this low pH-requiring protein.
To study the temporal relation between membrane re-
arrangements during fusion and the refolding of ASLV Env
into a 6HB, we utilized a strategy we originally developed
for HIV Env (Melikyan et al., 2000; Markosyan et al., 2003).
We arrested intermediates of fusion between effector cells
expressing ASLV EnvA and target cells expressing Tva
(Melikyan et al., 2004) and added the peptide R99. By
optimizing conditions to release the intermediate, we de-
termined whether R99 was able to inhibit fusion. We show
that receptor binding exposes the grooves of the coiled coil
and we delineate the stages at which low pH causes the R99-
binding sites of Env to become sequestered.
MATERIALS AND METHODS
Reagents and cells
The cells for all experiments in this study—effector 3T3 cells constitutively
expressing EnvA, as well as the target 293 cells expressing Tva950—have
been described previously (Narayan et al., 2003; Melikyan et al., 2004). The
inhibitory peptide, R99 derived from the C-terminal helical domain of the
TM domain of ASLV Env was originally synthesized at the University of
Pennsylvania (Earp et al., 2003). For the majority of the experiments
reported here, the peptide was prepared by Macromolecular Resources (Fort
Collins, Colorado). The sequence of R99, FNLSDHSESIQKKFQLM-
KEHVNKIG (N-acetylated and C-amidated), corresponds to residues 99–
123 of the TM subunit of Env A. Lauroyl-lysophosphatidylcholine (L-LPC)
was purchased from Avanti Polar Lipids (Alabaster, AL); CPZ (chlorprom-
azine) and BSA were obtained from Sigma (St. Louis, MO); and all
ﬂuorescent dyes (calcein AM, CMAC [7-amino-4-chloromethylcoumarin],
and DiI) were bought from Molecular Probes (Eugene, OR). A soluble
fragment of the entire 83 residue ectodomain of the Tva receptor (sTva) was
produced and puriﬁed from insect cells as described in (Balliet et al., 1999).
Cell-cell fusion experiments
A two-color video ﬂuorescence microscopy assay was used to monitor cell-
cell fusion, as has been described in detail (Melikyan et al., 2000, 2004).
Brieﬂy, the effector (E) cells that express EnvA were loaded with calcein
AM, and the target (T) cells expressing Tva950 (which we refer to as Tva)
were loaded with CMAC according to the manufacturer’s instructions.When
lipid dye spread was also monitored, a three-color assay was used in which,
in addition to aqueous dye labeling, the membranes of target cells were
labeled with the lipophilic ﬂuorescent dye, DiI. Effector and target cells were
mixed in 1:1 ratio, resuspended in DMEM supplemented with 0.1% BSA
(DMEM/BSA), and plated on 8-well slides (LabTech, Naperville, IL) coated
with poly-lysine. Unless stated otherwise, to induce fusion, E/T cells were
coincubated for 1 h at neutral pH at 37C and then exposed to pH 5.4 for 10
min via exchange of the bathing solution. Fifteen minutes after reneutraliza-
tion, the extent of cell-cell fusion was quantiﬁed in each well of the slide as
the fraction of ;100 E/T cell pairs for which the two aqueous dyes have
mixed. For experiments in which EnvA was receptor-activated by sTva,
effector cells were detached from a culture dish by incubation in divalent
cation-free PBS. They were pretreated with 500 ng/ml sTva for 30 min at
37C, and unbound sTva was removed by washing the cells three times with
DMEM/BSA. These effector cells were then coincubated with receptor-
deﬁcient 293T cells at 37C for 1 h and fusion was induced by a brief (2 min)
exposure to pH 5.4.
3292 Markosyan et al.
Biophysical Journal 87(5) 3291–3298
Arresting fusion at intermediate stages that
precede pore formation
The cold-arrested stage (CAS) of fusion was obtained as previously
described (Melikyan et al., 2004). In essence, after coincubating E/T cells,
temperature was brought to 4C and the pH was then transiently (usually for
10 min) lowered to 5.4 and returned to pH 7.2, yielding CAS. To create the
lipid-arrested stage (LAS) of fusion, E/T cells were incubated together and
0.2 mg/ml of L-LPC was then added at 23C for 3 min. The pH was lowered
to 5.4 for 3 min (in the presence of L-LPC) and after reneutralization,
temperature was reduced to 4C. The L-LPC was then removed at 4C by
washing three times with DMEM/BSA. This is deﬁned as LAS. When
L-LPC was removed at 23C rather than at 4C, some fusion occurred.
Fusion was triggered from CAS or LAS by raising the temperature to 37C
for 15 min. The R99 peptide was added at different stages of fusion, and
maintained unless indicated otherwise. The extent of fusion was then
monitored.
Arresting nascent fusion pores formed by
ASLV Env
Pore growth was controlled and monitored by a procedure that we
previously developed and described in detail (Melikyan et al., 2000;
Markosyan et al., 2003). In brief: effector cells, labeled with calcein AM,
and unlabeled target cells were adhered on cover slips and coincubated in
DMEM/BSA. The cover slips were placed in a chamber that was maintained
at 4C and the chamber was mounted on the stage of the microscope. Fusion
of selected cell pairs was triggered by lowering the pH of the solution
surrounding them to 5.4 by continuously applying a small volume of an
acidic solution around the cells, via a micropipette positioned adjacent to the
cells. Simultaneously with lowering of pH, the temperature of the selected
cell pairs was increased to 27C by illuminating with an IR laser diode. As
soon as fusion was detected in ﬂuorescence microscopy as the movement of
calcein from effector to target cell, temperature was returned to 4C by
shutting off the laser diode and pH was reneutralized by stopping the ﬂow of
the acidic solution. The ﬂuorescence intensity was proportional to the
concentration of calcein within each of the fused cells, so the rate of change
of ﬂuorescence yielded the pore permeability (Markosyan et al., 2003).
RESULTS
R99 inhibits fusion after EnvA is
receptor-activated
We coincubated effector and target cells and added R99 at
a sequence of arrested intermediates. After a 1-h coincuba-
tion of effector and target cells at pH 7.2 (37C), R99 was
added and pH was then lowered. The R99 potently inhibited
the cell-cell fusion that normally would have been induced
by acidiﬁcation to pH 5.4. The IC50 of 6.0 nM of R99 (Fig. 1)
is reasonably close to its IC50 of ;25 nM for inhibiting
ASLV A infection (Earp et al., 2003).
ASLV A virions fuse to target cells that are devoid of re-
ceptor when sTva is added to the solution; the extent of
infection varies nonlinearly with sTva concentration (Dam-
ico and Bates, 2000). We added sTva to effector cells and
receptor-deﬁcient target cells, maintaining neutral pH at
37C for 1 h, and then lowered pH. The extent of fusion
varied sigmoidally with the concentration of sTva; ;15 ng/
ml sTva yielded the half-maximal extent of fusion (Fig. 2 A).
This concentration of sTva is ~3-fold higher than the half-
maximal concentration required to induce infection of
receptor-deﬁcient cells by ASLV A virus (Damico and
Bates, 2000).
Adding sTva to ASLV A viral particles or to ectodomains
of EnvA induces hydrophobic binding to liposomes,
probably through insertion of Env’s fusion peptides (Damico
et al., 1998; Earp et al., 2003; Hernandez et al., 1997). The
state of Env after binding sTva in the absence of a target
membrane is known as ‘‘receptor-activated’’ (Mothes et al.,
2000). To determine whether the grooves of the coiled coil
were exposed after Env was receptor-activated, 500 ng/ml
sTva, either alone or mixed with 3.3 mM R99, was added to
effector cells in the absence of other cells. After a 30 min
incubation at 37C, all unbound sTva (and R99, if present)
was washed away. When R99 was not included in the mix,
coincubating these receptor-activated effector cells with cells
that did not contain receptor for 1 h at 37C followed by low
pH, led to extensive fusion (Fig. 2 B, bar 1). When R99 was
included in the mix, fusion was blocked (bar 2). As a control,
the effector cells were incubated with R99 and the peptide
then washed away. When these washed effector cells were
coincubated with receptor-deﬁcient cells for 1 h at 37 in
the presence of sTva, low pH led to extensive fusion
(bar 3). Coincubating effector and receptor-deﬁcient cells
did not yield fusion if sTva was not added (Fig. 2 A). Thus,
R99 bound to receptor-activated Env, but did not bind to
native, nonactivated EnvA. In other words, receptor-act-
ivation of EnvA either creates or exposes the grooves of the
coiled coil, but it does not induce folding of EnvA into a
6HB.
FIGURE 1 R99 peptide potently blocks EnvA-induced fusion to Tva-
expressing target cells. E/T cells were coincubated at 37C for 1 h and then
exposed to varied concentrations of R99 for 10 min. The pH was then brieﬂy
(5 min) lowered to 5.4 and the extent of fusion was determined after an
additional 15 min-incubation at neutral pH. The IC50 of R99 was determined
by ﬁtting the experimental data with a Langmuir binding isotherm, as
described previously (Markosyan et al., 2002). Error bars are standard errors
of the mean. Each point was obtained from at least three independent
measurements, each carried out in duplicate.
ASLV Env Refolding at Low pH 3293
Biophysical Journal 87(5) 3291–3298
Fusion from LAS is resistant to peptide inhibition,
suggesting that 6HB formation can occur before
membrane merger
After effector cells expressing EnvA bind to Tva-expressing
target cells, pH must be lowered for cell-cell fusion to occur
(Melikyan et al., 2004). The incorporation of LPC as a lipid
component into membranes has been found to inhibit fusion
in all systems for which it has been tested. Incorporated LPC
is thought to inhibit fusion by preventing membranes from
bending in the direction necessary for hemifusion to occur
(Chernomordik et al., 1995).
Preincubating E/T cells at neutral pH for 1 h at 37C,
adding LPC, and then lowering pH to 5.4 at 23C did not
lead to fusion (Fig. 3), whereas the same protocol without the
addition of LPC led to efﬁcient fusion (Fig. 3 A, bar 1).
When LPC had been added, reneutralization and subsequent
removal of LPC from the cell membranes by repetitive
washings at a temperature below 8C did not result in
aqueous dye mixing (bar 2). At this LAS of fusion, lipid dye
had also not yet spread (data not shown). But increasing
temperature at this point to 37C (at neutral pH), resulted in
a signiﬁcant extent of fusion (bar 3), showing that LPC’s
inhibitory effect was largely reversible. Because fusion could
proceed at neutral pH after the removal of LPC, we conclude
that low pH-dependent conformational changes of EnvA
precede hemifusion. CPZ did not lead to fusion when added
(at 4C) either immediately (data not shown) or 10 min (bar
5) after creating LAS. This indicates that LAS is a prehemi-
fusion state and did not progress to restricted hemifusion.
When a high concentration of R99 was added to E/T cells
captured at LAS, the extent of fusion induced by raising
temperature to 37C (Fig. 3 A, bar 4) was comparable to that
in the absence of peptide (bar 3). The ﬁnding that R99 does
not inhibit fusion demonstrates that grooves of the coiled coil
FIGURE 2 (A) Pretreatment of effector cells with sTva promotes
conformational changes in EnvA that allow low pH to induce fusion to
receptor-deﬁcient cells. 3T3/EnvA cells were coincubated with 293T cells at
37C for 1 h in the presence of the indicated concentrations of sTva. Cell-cell
fusion was then triggered by lowering pH to 5.4 for 10 min. (B) Binding
sTva to EnvA causes exposure of R99 binding sites. Coincubating effector
and receptor-deﬁcient 293T cells did not lead to fusion (A). Pretreating the
effector cells with sTva yielded extensive fusion (ﬁrst bar). When both sTva
and R99 were present during the pretreatment of the effector cells, fusion to
receptor-deﬁcient cells was negligible (second bar). Pretreating effector cells
with R99 alone, followed by extensive washing and then coculturing with
receptor-deﬁcient cells in the presence of sTva led to an appreciable extent of
fusion (third bar). Five hundred ng/ml sTva and 3.3 mM R99 were used for
experiments of panel B. Error bars are standard errors on the mean for at least
four measurements.
FIGURE 3 The LAS, but not the CAS, of ASLV Env-induced fusion is
resistant to R99 peptide. (A) All procedures to create LAS were performed in
the control (ﬁrst bar), except that 0.2 mg/ml L-LPC was not included in any
solutions. Fusion did not occur when LAS was created (second bar). But
raising temperature to 37C for 15 min resulted in signiﬁcant fusion (third
bar). Adding R99 (1.7 mM) at LAS did not signiﬁcantly reduce the extent of
fusion upon raising temperature to 37C (fourth bar). Adding CPZ at LAS
did not lead to fusion (ﬁfth bar). (B) Fusion did not occur when CAS was
created (ﬁrst bar). A subsequent incubation at 37C (pH 7.2) for 15 min
(second bar) or an exposure to 0.5 mM CPZ for 2 min at 4C (fourth bar)
resulted in extensive fusion. Incubating the cells with R99 (1.7 mM) for
10 min (at 4C) after creating CAS abolished the 37C-induced (third bar)
and suppressed the CPZ-induced (ﬁfth bar) fusion at 4C.
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are no longer accessible, and suggests that EnvA is already
folded into a 6HB at LAS. If indeed EnvA has folded into
a bundle at LAS, it would mean that ASLV EnvA can fold
into a 6HB before membrane merger.
Local hemifusion can occur before all copies of
Env fold into 6HBs
We have previously shown (Melikyan et al., 2004) that by
reducing pH to 5.4 at 4C, an intermediate—referred to as
a CAS—is captured (see Materials and Methods). Neither
lipid (data not shown) nor aqueous dye (Fig. 3 B, bar 1) has
spread at CAS. If lipid dye is observed to spread in the absence
of fusion pores, hemifusion has certainly occurred. But many
states that probably are states of hemifusion do not allow
movement of dye between cells. Such states are known as
‘‘restricted hemifusion’’ (Chernomordik et al., 1998). It is
generally agreed that when the addition of CPZ promotes
aqueous dye transfer, the cells were in a state of restricted
hemifusion (reviewed in Cohen et al., 2002). CAS is readily
converted to full fusion by treating cells with CPZ at neutral
pH, 4C (Fig. 3 B, bar 4, also see Melikyan et al., 2004),
implying that CAS is a state of restricted hemifusion. Fusion
was induced from CAS by raising temperature to 37C at
neutral pH (bar 2): aqueous dye spreadwas observed formore
than 60%of the cell pairs. CAS is relatively stable at 4C:CPZ
promotes fusion (at neutral pH) to almost the same extent
when it is added 45 min after creating CAS (data not shown)
as when added immediately (bar 4). This indicates that the
state of restricted hemifusion is stable. But the ability of Env
to induce fusion from CAS decreases with time. The extent of
fusion was greater upon raising temperature to 37C
immediately after creating CAS (bar 2) than 45 min later
(data not shown). Also, fusion from CASwas still completely
inhibited when R99 was added 45 min after creating CAS
(data not shown). Thus CAS does not evolve to a more
advanced statewith time at 4C.This is in contrast to inﬂuenza
HAwhere holding a restricted-hemifusion state, equivalent to
CAS, for extended times at 4C can promote advancement to
a more downstream state (Chernomordik et al., 1998).
When R99 was added at CAS and temperature raised to
37C, fusion did not occur (Fig. 3 B, bar 3). Because R99
inhibited fusion, not all copies of Env that participate in
fusion had completed their folding into 6HB at CAS
(assuming bundle formation is irreversible). Unexpectedly,
the addition of R99 also strongly reduced the ability of CPZ
to induce fusion at the point of CAS (bar 5). This implies that
binding of R99 to prebundle conformations of the TM
subunit caused the local lipid connections between the
hemifused E/T cells at CAS to dissociate. In other words,
upon binding R99, Env converts into a state that no longer
supports hemifusion. Thus, prebundle conﬁgurations of Env
and the hemifusion state are reversible, and speciﬁc
prebundle conﬁgurations of the TM subunits are critical for
sustaining the state of local hemifusion.
R99 does not inhibit pore growth
The growth of the initial ASLV Env-induced fusion pore can
be arrested by lowering temperature (Melikyan et al., 2004).
After coincubating effector and target cells at neutral pH, we
acidiﬁed at 27C and, immediately after pore formation, we
lowered temperature to 4C and reneutralized the solution
(Fig. 4, A and B, downward arrow). The rate of aqueous dye
transfer between the cells decreased, showing that pore
growth ceased and, in fact, pore size even decreased (Fig. 4).
When temperature was raised to 37C, pore growth im-
mediately resumed (Fig. 4A, upward arrow). Adding the R99
peptide before raising temperature did not hinder pore growth
(Fig. 4 B). Thus, Env had either already folded into a 6HB by
the time a pore formed (even when formed at the relatively
low temperature of 27C), or it folded into a bundle soon after
pore formation, before R99 could be added.
DISCUSSION
In this study, we captured ASLV EnvA-induced fusion at a
receptor-activated state, at LAS, at CAS, and at a small pore.
At each arrested stage, we determined the ability of R99 to
inhibit aqueous dye transfer and the ability of either CPZ or
FIGURE 4 Small fusion pores formed by ALSV Env are not affected by
R99. Fusion was triggered by local perfusion of selected cell pairs with
a solution at pH 5.4 and simultaneous raising of temperature from 4C to
27C. Immediately after calcein began to transfer into the target cell, the
temperature was dropped back to 4C (downward arrows) and the bathing
solution was replaced by one containing 5 mMR99 peptide at neutral pH (B,
arrowhead) or, in control experiments, without peptide (A, arrowhead).
After holding the temperature at 4C for an additional 3–4 min, temperature
was quickly raised to 37C (upward arrows). The average ﬂuorescence of
representative target cells as a result of calcein transfer from the effector cell
is shown by the noisy solid lines. The pore permeability (open circles) was
calculated from the rate of calcein transfer, as previously described
(Markosyan et al., 2003).
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temperature to effect aqueous dye transfer. As a result, we
were able to make several characterizations (Fig. 5). First,
since low pH is necessary to create CAS and LAS, it appears
that low pH is necessary for hemifusion to occur. Second,
using low temperature to arrest a state of hemifusion (i.e.,
CAS), we found that adding R99 causes the merged mem-
branes (CAS) to revert back to separate membranes (Fig. 5,
prebundle to extended conformation). We assume that R99
causes this reversion by binding to the grooves of the coiled
coil of Env. Third, the folding of ASLV Env into a 6HB
requires low pH. Fourth, grooves of the central coiled coil of
Env become occluded from R99 at low pH, 37C when
membrane merger is prevented by the presence of LPC (Fig.
5, LAS). In contrast, exposing Env to acidic pH at low
temperature keeps the grooves exposed while promoting
membrane merger (CAS). Fifth, because different triggers are
required to induce fusion from the receptor-activated state
and from CAS, we can conclude that there are at least two
distinct prebundle conﬁgurations. The receptor-activated
conformation requires low pH to induce fusion. The
prebundle conﬁguration of CAS no longer requires low pH,
but does require high temperature for fusion to occur.
R99 has the amino acid sequence of the portion of the
C-terminal segment expected to pack into the grooves of the
coiled coil. In the absence of a crystal structure, one cannot be
certain that R99 does indeed bind to the grooves to prevent
bundle formation and if it does, that this is the only site of R99
binding. To formulate mechanistic interpretations to our
experimental results, we assume that the sole consequence of
R99 binding is to prevent EnvA from folding into a bundle.
Because bundle formation is probably irreversible, it is
expected that R99 would no longer be able to bind to EnvA
(and thereby inhibit fusion) once EnvA has folded into a
bundle. Therefore, if the addition of R99 inhibits fusion, one
can conclude that EnvA has not yet folded into a 6HB at the
stage of addition. If R99 no longer inhibits fusion, either the
6HB has formed or the grooves are no longer exposed for
other reasons (e.g., steric hindrance). Experimental means to
distinguish between the two possibilities are not yet available.
The occurrence of conformational changes and oligomer-
ization of ASLV Env by receptor-activation followed by low
pH has been tracked bymigration of Env inmildly denaturing
SDS gels (Mothes et al., 2000;Matsuyama et al., 2004; Smith
et al., 2004). After receptor-activating EnvA of ASLV
particles and adding liposomes, the initial monomeric 37
kD band is reduced, and 70 kD and 150 kD bands appear.
Lowering pH after receptor-activation results in a 90–100 kD
band (as well as higher molecular weight bands, .150 kD)
(Matsuyama et al., 2004; Smith et al., 2004). The presence of
R99 or LPC prevented the formation of the 90–100 kD band,
leading to the proposal that this band represents either a 6HB
or a more complete ﬁnal trimeric hairpin (Matsuyama et al.,
2004; Smith et al., 2004). The fact that R99 prevented the
formation of this band (Matsuyama et al., 2004) is consistent
with the assumption that R99 inhibits fusion by preventing
bundle formation. If the 90–100 kD band represents the
FIGURE 5 Proposed sequence for ASLV
Env-refoldings and lipid rearrangements that
lead to fusion pore formation. The progression
of conformational changes in Env: an extended
conformation after receptor-activation (left
panel), prebundles (i.e., CAS, lower panel),
6HB (LAS, upper panel) and the ﬁnal trimeric
hairpin conformation (small fusion pore, right
panel). LPC molecules that disfavor membrane
hemifusion are shown by open triangles. For
visual clarity, only the TM subunit of Env is
shown. Shaded cylinders are C-terminal seg-
ments and open cylinders are N-terminal seg-
ments that form the coiled coil. A relatively long
intervening stretch of amino acids between the
C-terminal segments and MSDs allows a 6HB
for formwithout necessitating close approach of
fusion peptides and MSDs. Prebundle confor-
mations are capable of inducing hemifusion at
low temperature (CAS). 6HBs have not formed
at this state. In our experiments, LAS was
created after removal of L-LPC at 4C.
Although not strictly correct, we illustrate, for
artistic convenience, LAS as a state at 37C in
the presence of L-LPC. At LAS, the grooves of
the coiled coil are no longer exposed and thus
the 6HBs may have formed. Formation of the
trimeric hairpin promotes creation of the fusion
pore and/or its enlargement.
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complete trimeric hairpin (rather than the 6HB which
comprises only a portion of the trimeric hairpin as discussed
below), the biochemical studies and our functional measures
would be in complete agreement.
For the same reasons we discussed for HIV Env
(Markosyan et al., 2003), we consider it more likely that the
6HB of ASLV Env forms by the sequential insertion of the
three C-terminal segments into the grooves of the coiled coil,
rather than by simultaneous insertion (Fig. 5). Even though
the 6HB is stable, unable to revert to upstream conﬁgurations,
this may not be the case for prebundle conﬁgurations: the
insertion of one or two (but not all three) C-terminal segments
into grooves may be reversible. If this is the situation, binding
of the synthetic C-peptide R99 into grooves would drive Env
with one or two inserted natural C-terminal segments into
earlier, more upstream prebundle conﬁgurations. We conjec-
ture that late prebundle conﬁgurations are necessary to
maintain the state of hemifusion at CAS.
For several viruses, such as HIV, SV5, human T-cell
leukemia virus, and others, peptides designed against
formation of 6HBs have been shown to prevent viral infection
and fusion (Jiang et al., 1993; Lambert et al., 1996; Russell
et al., 2001; Pinon et al., 2003; Wild et al., 1994). These
viruses fuse directly to the plasmamembrane at neutral pH. In
contrast, in the case of viruses that utilize low pH alone (i.e.,
without receptor-activation) for fusion, no peptide directed
against formation of a 6HB has yet been shown to inhibit
fusion. It is possible that prehairpin conﬁgurations of neutral
pH fusion proteins exist for appreciably longer times than low
pH proteins. This would expose the grooves of the coiled coil
of neutral pH fusion proteins for relatively long times. It
would also account for the generally slower fusion kinetics of
proteins that fuse at neutral pH (Hoekstra et al., 1984; Pal et al.,
1988; Bron et al., 1993; Plonsky and Zimmerberg, 1996;
Melikyan et al., 2000; Markosyan et al., 2001). For ASLV,
low pH can induce fusion only after receptor-activation
exposes the grooves of the coiled coil of Env (Fig. 2) and the
fusion peptides have inserted into the target membrane
(Melikyan et al., 2004). Because the neutral pH steps in the
process are appreciably slower than the low pH steps
(Melikyan et al., 2004), the grooves of ASLV Env should
be exposed to R99 for long times.
For HIV Env and SV5 F, bundle formation requires
membranemerger (Melikyan et al., 2000; Russell et al., 2001)
and for HIV Env, bundle formation continues after pore
formation (Markosyan et al., 2003). For these proteins, the
6HB comprises almost the entire trimeric hairpin and bundle
formation alone should bring the MSDs and the fusion
peptides into close proximity. For inﬂuenza HA, local
hemifusion occurs before the formation of the trimeric hairpin
has been completed (Borrego-Diaz et al., 2003), but HAmust
complete its folding into a trimeric hairpin for fusion to occur
(Park et al., 2003) and for the pore to grow (Borrego-Diaz
et al., 2003). Because there is a long intervening stretch of
amino acids (termed a ‘‘leash’’; Park et al., 2003) between the
C-terminal helices of the 6HB and theMSDs, the formation of
the 6HB, per se, is not sufﬁcient to bring theMSDs and fusion
peptides into proximity. But the creation of auxiliary
structures within the ﬁnal trimeric hairpin does bring the
MSDs and fusion peptides into proximity (Chen et al., 1999).
In short, for some proteins, such as HA, there is a subtle but
important difference between the 6HB and trimeric hairpin
structures, whereas for others, such as HIV Env, there is no
distinction between the two.
We have suggested that the ﬂexibility conferred by the
long intervening stretch of HA allows the 6HB to form before
the trimeric hairpin is complete (Borrego-Diaz et al., 2003). It
is not known whether there is an intervening sequence
between the 6HBs and the MSDs for ASLV Env. Based on
the crystal structure of GP2 of Ebola and the amino acid
sequence of ASLV Env, if the intervening sequence exists, it
must be shorter (;20 amino acid residues) than that of
inﬂuenza HA (;60 amino acid residues). But if the structure
of this short intervening sequence were ﬂexible, a 6HB could
form without forcing the MSDs and fusion peptides into
proximity; an auxiliary structure would be required to bring
about this proximity. In view of the inability of R99 to inhibit
fusion when added at LAS, the 6HB of ASLV Env may be
able to form before membrane merger, even though the
trimeric hairpin cannot. We propose that for all class I
proteins, the formation of the trimeric hairpin is tightly
coupled to creation of the fusion pore and/or its growth.
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